Rennova Health, Inc. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was USD 15.986 million compared to USD 14.548 million a year ago. Operating loss was USD 16.330 million compared to USD 13.224 million a year ago. Net loss was USD 48.033 million compared to USD 14.022 million a year ago. Basic loss per share was USD 0.03 compared to USD 24.53 a year ago. Basic loss per share from continuing operations was USD 0.03 compared to USD 24.49 a year ago.